“The markets are dead!”: Emerita Resources (EMO.V) shows otherwise with massive upside coming
Lithium Ionic (LTH.V) is up 50% in 3 months, and is moving toward production
Digital Twinning, and how EdgeTI (CTRL.V) is a serious story you’ve never heard of
Bionxt Solutions (BNXT.C): Seeking to confirm national-level cancer drug patent
Why Prospera Energy (PEI.V) might be a transformational investment opportunity in Canadian oil & gas
Sparc AI (SPAI.C) completes development of drone advanced target acquisition system
Radio and TV personality, Jody Vance, speaks with Steve Saviuk, president and CEO of Valeo Pharma (VPH.C) to get a close look at the company and it’s product pipeline including Hesperco, an immune support anti-oxidant currently involved in clinical trials at the Montreal Heart Institute. What could this mean for investors? Tune in!
Disclaimer: http://bit.ly/EGdisclaimer
